Inventurus Board Approves $40M Investment in IKS Inc with Detailed Structure
Inventurus Knowledge Solutions' board approved a $40 million additional investment in its wholly owned subsidiary IKS Inc during a March 13, 2026 meeting. The investment will be executed in tranches, starting with $20 million for 31,096 shares at $643.19 per share, with completion targeted by May 31, 2026. IKS Inc, a Delaware-incorporated healthcare technology company, reported revenue from operations of ₹6,941.11 million in FY 2024-25.

*this image is generated using AI for illustrative purposes only.
Inventurus Knowledge Solutions has announced that its Board of Directors approved an additional investment of up to $40 million in IKS Inc, its wholly owned subsidiary, during a board meeting held on March 13, 2026.
Board Meeting Details
The Board of Directors meeting commenced at 07:10 p.m. (IST) and concluded at 07:20 p.m. (IST) on March 13, 2026. The company has informed both BSE and NSE about this decision under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Meeting Parameter: | Details |
|---|---|
| Meeting Date: | March 13, 2026 |
| Meeting Duration: | 07:10 p.m. to 07:20 p.m. (IST) |
| Investment Approved: | Up to $40 million |
| Target Entity: | IKS Inc (wholly owned subsidiary) |
Investment Structure and Pricing
The investment will be executed in tranches, with the first tranche involving $20 million. The company will acquire up to 31,096 equity shares at $643.19 per share for this initial investment. The remaining 50% of the approved amount will be deployed in due course, with completion targeted on or before May 31, 2026.
| Investment Details: | Specifications |
|---|---|
| Total Approved Amount: | Up to $40 million |
| First Tranche: | $20 million |
| Share Price: | $643.19 per share |
| Shares to be Acquired: | Up to 31,096 shares |
| Completion Timeline: | On or before May 31, 2026 |
IKS Inc Financial Performance
IKS Inc, incorporated on September 19, 2006, under Delaware state laws, operates as a care enablement platform providing technology-enabled solutions for healthcare providers. The subsidiary has demonstrated consistent revenue performance over the past three years.
| Financial Performance: | FY 2024-25 (₹ Mn) | FY 2023-24 (₹ Mn) | FY 2022-23 (₹ Mn) |
|---|---|---|---|
| Revenue from Operations: | 6,941.11 | 7,027.85 | 6,054.66 |
| Other Income: | 55.81 | - | - |
| Total Income: | 6,996.92 | - | - |
Strategic Rationale
This additional investment represents a cash consideration transaction conducted on an arm's length basis. IKS Inc assists U.S.-based healthcare service providers in delivering better, safer, and more efficient care through a combination of outsourcing and technology solutions. The investment will support the subsidiary's business activities while maintaining Inventurus Knowledge Solutions' complete ownership of IKS Inc.
Historical Stock Returns for Inventurus Knowledge Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.70% | +1.23% | -18.48% | -15.18% | -8.69% | -32.62% |


































